Clinical Trials in Batumi, Ajaria

Find clinical trials in Batumi, Ajaria. Discover local research opportunities and treatment options in your area.

7 Active Trials Found in Batumi

Showing 7 trials on this page

Page 1 of 1

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT ID: NCT06052059

This clinical trial is studying a new medication called tulisokibart (MK-7240) to see if it is effective and safe for people with moderately to severely active ulcerative colitis, a condition that ...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004)

NCT ID: NCT06345729

This clinical trial is investigating a new combination treatment for patients with a specific type of advanced lung cancer known as non-small cell lung cancer (NSCLC). Participants in this study wi...

Recruiting

Phase: PHASE3 Conditions: Non-small Cell Lung Cancer

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT ID: NCT06430801

This clinical trial is studying a new medication called tulisokibart, which is being tested for its effectiveness and safety in treating people with moderate to severe Crohn's disease. Crohn's dise...

Recruiting

Phase: PHASE3 Conditions: Crohn's Disease

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

NCT ID: NCT06667700

This clinical trial is studying a medication called molnupiravir to see if it can help prevent severe illness from COVID-19 in people who are at high risk. COVID-19 usually causes mild symptoms, bu...

Recruiting

Phase: PHASE3 Conditions: Coronavirus Disease (COVID-19)

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

NCT ID: NCT06054555

This clinical trial is studying a new treatment called ABP 206 to see how it compares to an existing medication known as OPDIVO® (Nivolumab) for patients with advanced melanoma that cannot be surgi...

Recruiting

Phase: PHASE3 Conditions: Melanoma

A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)

NCT ID: NCT05816252

This clinical trial is studying a new treatment called SKB264 for patients with advanced or metastatic non-small cell lung cancer (NSCLC), a type of lung cancer that has spread beyond its original ...

Recruiting

Phase: PHASE2 Conditions: Non-small Cell Lung Cancer

Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis

NCT ID: NCT06930365

This clinical trial is looking to compare the effectiveness and tolerability of two different skin creams for people with atopic dermatitis, a condition that causes red, itchy, and flaky skin. The ...

Recruiting

Phase: NA Conditions: Atopic Dermatitis, Eczema

Search All Trials Browse All Locations